Average Co-Inventor Count = 3.74
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Signal Pharmaceuticals, Inc. (21 from 169 patents)
2. Celgene Corporation (2 from 550 patents)
23 patents:
1. 12084499 - SIRP-α binding proteins and methods of use thereof
2. 11591390 - SIRP-α binding proteins and methods of use thereof
3. 11590139 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
4. 11166950 - Treatment of cancer with TOR kinase inhibitors
5. 10940152 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
6. 10646493 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
7. 10576085 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
8. 10391092 - Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy
9. 10183019 - Treatment of cancer with dihydropyrazino-pyrazines
10. 9980963 - Treatment of cancer with dihydropyrazino-pyrazines
11. 9937169 - Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy
12. 9937170 - Treatment of cancer with TOR kinase inhibitors
13. 9782427 - Methods for treating cancer using TOR kinase inhibitor combination therapy
14. 9737541 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
15. 9630966 - Treatment of cancer with dihydropyrazino-pyrazines